Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
![]() |
|||||
GSE100530 |
Mutational landscape of splicing genes and functional consequences across 33 cancer types
|
|
6 | Silvia Buonamici | Dec 20, 2017 | |||
GSE94999 |
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6]
|
|
9 | Silvia Buonamici | Dec 20, 2017 | |||
GSE94528 |
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562]
|
|
12 | Silvia Buonamici | Dec 20, 2017 | |||
GSE95352 |
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients
|
|
13 | Silvia Buonamici | Jun 27, 2017 | |||
GSE85712 |
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation
|
|
|
15 | Silvia Buonamici | Aug 17, 2016 | ||
GSE95011 |
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers
|
|
21 | Silvia Buonamici | Dec 20, 2017 | |||
GSE96917 |
Splicing Modulators Act at the Branch Point Adenosine Binding Pocket Defined by the PHF5A-SF3b Complex
|
|
24 | Silvia Buonamici | May 25, 2017 | |||
GSE72790 |
Cancer associated SF3B1 hotspot mutations induce cryptic 3' splice site selection through use of a different branch point
|
|
|
72 | Silvia Buonamici | Sep 08, 2015 |